Morgan Stanley has illustrated robust operating performance since the turn of the year. MS's wealth and investment management segments show non-cyclical growth potential, while investment banking ...

Morgan Stanley reported slightly better than expected Q4 results - and the stock is up as much as 4% in pre-market trading. Although results were solid, net income contracted by about 40% as compared ...

As previously reported, Morgan Stanley upgraded Synchrony (SYF) to Overweight from Underweight with a price target of $82, up from $40. The firm adds EPS upside from late fee rule preparatory actions ...

Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc GEHC with an Equal-Weight rating and a price target of $76. The analyst said the company's peers had seen a ...

Morgan Stanley analyst Patrick Wood raised the firm’s price target on GE HealthCare (GEHC) to $80 from $74 and keeps an Equal Weight rating on the ...